Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fink

Showing results (71-80 of 418) with videos related to

Pageof 42
Sort By:
Seminars in Respiratory Infections|December 1, 1994
Effect of critical illness on microbial translocation and gastrointestinal mucosa permeabilityM P Fink
Journal of Internal Medicine|March 30, 2007
Ethyl pyruvate: a novel anti-inflammatory agentM P Fink
Current Drug Targets|April 14, 2007
Ethyl pyruvate: a novel treatment for sepsisMitchell P Fink
Critical Care Medicine|January 1, 1992
Intestinal epithelial restitution after ischemiaM P Fink
Critical Care Medicine|July 18, 2009
Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1Mitchell P Fink
Critical Care Medicine|March 20, 2012
Pharmacological effects of inhaled methane: plausible or not?Mitchell P Fink
Critical Care Medicine|February 1, 1993
Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharideM P Fink
Critical Care Medicine|August 28, 2013
Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effectiveMitchell P Fink
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 7, 2015
Cytopathic hypoxia and sepsis: is mitochondrial dysfunction pathophysiologically important or just an epiphenomenonMitchell P Fink
Critical Care (London, England)|February 13, 2015
Analyzing the value of monitoring duodenal mucosal perfusion using photoplethysmographyMitchell P Fink
Pageof 42

Showing results (71-80 of 418) with videos related to

Sort By:
Pageof 42
Seminars in Respiratory Infections|December 1, 1994
Effect of critical illness on microbial translocation and gastrointestinal mucosa permeabilityM P Fink
Journal of Internal Medicine|March 30, 2007
Ethyl pyruvate: a novel anti-inflammatory agentM P Fink
Current Drug Targets|April 14, 2007
Ethyl pyruvate: a novel treatment for sepsisMitchell P Fink
Critical Care Medicine|January 1, 1992
Intestinal epithelial restitution after ischemiaM P Fink
Critical Care Medicine|July 18, 2009
Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1Mitchell P Fink
Critical Care Medicine|March 20, 2012
Pharmacological effects of inhaled methane: plausible or not?Mitchell P Fink
Critical Care Medicine|February 1, 1993
Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharideM P Fink
Critical Care Medicine|August 28, 2013
Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effectiveMitchell P Fink
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 7, 2015
Cytopathic hypoxia and sepsis: is mitochondrial dysfunction pathophysiologically important or just an epiphenomenonMitchell P Fink
Critical Care (London, England)|February 13, 2015
Analyzing the value of monitoring duodenal mucosal perfusion using photoplethysmographyMitchell P Fink
Pageof 42